| Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity V Mathews, B George, KM Lakshmi, A Viswabandya, A Bajel, ... Blood 107 (7), 2627-2632, 2006 | 416 | 2006 |
| Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data V Mathews, B George, E Chendamarai, KM Lakshmi, S Desire, ... Journal of Clinical Oncology 28 (24), 3866-3871, 2010 | 305 | 2010 |
| Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity CM Rudin, W Liu, A Desai, T Karrison, X Jiang, L Janisch, S Das, ... Journal of clinical oncology: official journal of the American Society of …, 2008 | 248 | 2008 |
| Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation A Srivastava, B Poonkuzhali, RV Shaji, B George, V Mathews, M Chandy, ... Blood 104 (5), 1574-1577, 2004 | 190 | 2004 |
| Transporter-mediated protection against thiopurine-induced hematopoietic toxicity P Krishnamurthy, M Schwab, K Takenaka, D Nachagari, J Morgan, ... Cancer research 68 (13), 4983-4989, 2008 | 161 | 2008 |
| Acute myeloid leukaemia: challenges and real world data from India C Philip, B George, A Ganapule, A Korula, P Jain, AA Alex, KM Lakshmi, ... British journal of haematology 170 (1), 110-117, 2015 | 131 | 2015 |
| Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell … R Thirugnanam, B George, E Chendamarai, KM Lakshmi, ... Biology of Blood and Marrow Transplantation 15 (11), 1479-1484, 2009 | 116 | 2009 |
| Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience B George, V Mathews, B Poonkuzhali, RV Shaji, A Srivastava, M Chandy Leukemia 18 (10), 1587-1590, 2004 | 94 | 2004 |
| Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia AP Rajkumar, B Poonkuzhali, A Kuruvilla, M Jacob, KS Jacob International clinical psychopharmacology 28 (1), 50-56, 2013 | 92 | 2013 |
| Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms B Poonkuzhali, J Lamba, S Strom, A Sparreboom, K Thummel, P Watkins, ... Drug metabolism and disposition 36 (4), 780-795, 2008 | 89 | 2008 |
| A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression C Marzolini, RG Tirona, G Gervasini, B Poonkuzhali, M Assem, W Lee, ... Molecular endocrinology 21 (8), 1769-1780, 2007 | 78 | 2007 |
| Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2 S Karathedath, BM Rajamani, SM Musheer Aalam, A Abraham, ... PloS one 12 (5), e0177227, 2017 | 75 | 2017 |
| Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience V Mathews, P Balasubramanian, RV Shaji, B George, M Chandy, ... American journal of hematology 70 (4), 292-299, 2002 | 75 | 2002 |
| Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy E Chendamarai, P Balasubramanian, B George, A Viswabandya, ... Blood, The Journal of the American Society of Hematology 119 (15), 3413-3419, 2012 | 70 | 2012 |
| Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia–the role of busulfan pharmacokinetics in determining outcome M Chandy, P Balasubramanian, SV Ramachandran, V Mathews, ... Bone marrow transplantation 36 (10), 839-845, 2005 | 67 | 2005 |
| Glutathione S-transferase activity influences busulfan pharmacokinetics in patients with beta thalassemia major undergoing bone marrow transplantation B Poonkuzhali, M Chandy, A Srivastava, D Dennison, R Krishnamoorthy Drug metabolism and disposition 29 (3), 264-267, 2001 | 55 | 2001 |
| Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia A Abraham, S Varatharajan, S Abbas, W Zhang, RV Shaji, R Ahmed, ... Pharmacogenomics 13 (3), 269-282, 2012 | 52 | 2012 |
| RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia A Abraham, S Varatharajan, S Karathedath, C Philip, KM Lakshmi, ... Pharmacogenomics 16 (8), 877-890, 2015 | 50 | 2015 |
| Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients … AP Rajkumar, B Poonkuzhali, A Kuruvilla, A Srivastava, M Jacob, ... Psychopharmacology 224, 441-449, 2012 | 47 | 2012 |
| High-performance liquid chromatographic method for quantification of busulfan in plasma after derivatization by tetrafluorothiophenol MH Quernin, B Poonkuzhali, Y Médard, D Dennison, A Srivastava, ... Journal of Chromatography B: Biomedical Sciences and Applications 721 (1 …, 1999 | 47 | 1999 |
Vikram MathewsProfessor of Clinical HematologyVerified email at cmcvellore.ac.in
